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SUMMARY
The incidence of Bell’s palsy has been estimated in a health district of a major Italian city, taking also into consideration the potential 
risk factors that might in uence the occurrence of Bell’s palsy. A matched case-control was therefore designed, by collecting data from 
the Emergency Departments of four Hospitals belonging to the same Health District in Rome (Italy), coordinated by a tertiary referral 
centre University Hospital. All patients affected by Bell’s palsy within the health district and four controls for each case were included. 
Controls were selected from other ENT patients, and were matched for hospital admission, week of disease onset, and climate condi-
tions. Information regarding possible risk factors was collected using standardized telephone interviews. The resulting dataset was 
analyzed using multiple conditional logistic regression. The study group comprised 381 patients with acute, unilateral, peripheral facial 
palsy, clinically diagnosed as Bell’s palsy observed between 1st January 2006 and 31st December 2008. The cumulative incidence of 
Bell’s palsy was found to be 53.3/100.000/year. Among the risk factors, age was found to in uence onset of Bell’s palsy, with an odds 
ratio of 2% for each one-year increase in age, with a linear trend (95% CI = 1-3%; p = 0.005). Bell’s palsy was found to occur with an 
annual incidence close to previous reports. Among the possible known risk factors (diabetes, pregnancy, etc.), only aging was found to 
play a signi cant role.
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RIASSUNTO
L’incidenza di paralisi di Bell è stata calcolata in un Distretto Sanitario di una grande città italiana, analizzando anche i potenziali 
fattori di rischio che potrebbero in uenzarla. È stato disegnato uno studio caso-controllo, raccogliendo i dati dai Dipartimenti di 
Emergenza di quattro Ospedali romani, coordinato dall’Ospedale Universitario di riferimento. Sono stati esaminati tutti i pazienti 
affetti da paralisi di Bell nell’ambito del medesimo Distretto Sanitario e quattro controlli per ciascun caso. I controlli sono stati sele-
zionati da pazienti giunti nello stesso giorno presso lo stesso Ospedale del paziente/caso, affetti da altra patologia di ambito otorino-
laringoiatrico. Sono state anche prese in considerazione sia la settimana dell’anno in esame che le relative condizioni meteorologiche. 
Le informazioni sui possibili fattori di rischio sono state ottenute mediante intervista telefonica. I risultati sono stati analizzati me-
diante regressione logistica multipla. Il gruppo di studio è risultato composto da 381 pazienti con paralisi facciale periferica acuta ed 
unilaterale, diagnosticati come paralisi di Bell tra il 1° gennaio 2006 ed il 31 dicembre 2008. L’incidenza è risultata pari a 53,3 casi 
per 100.000 abitanti per anno, dunque non discostante da precedenti rilievi della letteratura. Tra i fattori di rischio, l’invecchiamento 
è risultato l’unica variabile in grado di in uenzare l’insorgenza di paralisi di Bell, con in media la possibilità di un incremento del 
2% per anno, con tendenza lineare (95% CI = 1-3%; p = 0,005).
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Introduction
Bell’s palsy (BP) accounts for almost 75% of all cases 
of acute facial palsy (FP), the incidence varying in the 
different countries around the world. Different rates of 
incidence have been reported, in the medical literature, 
depending on the geographical regions under study.
The annual incidence has been reported to range between 
11 and 40 or 8 and 240 cases per 100,000 subjects 1 2.
The aetiology of BP is still unclear: viral infections, vascu-
lar disease, hypertension and diabetes have been indicated 
as possible causal agents 3-6. Adour, in 1977, suggested that 
reactivation of Herpes simplex type 1 virus may play a 
major role in the pathogenesis of BP 7 and, more recently, Epidemiology of Bell’s palsy
199
increasing evidence of reactivation of latent HSV-1 from 
cranial nerve ganglia has been reported 8 9.
BP would appear to be more frequent in the Japanese 
population  and  in  the  Mediterranean  Countries.  It  is 
still unclear whether these differences are due to racial 
susceptibility, or rather to environmental, geographic or 
climatic factors 10. Experimental  ndings would support 
a  signi cant  role  played  by  low  temperatures,  which 
might be related to a higher incidence of BP in the colder 
period of the year 1. The age peak incidence occurs be-
tween 15 and 45 years 11. Females and males are equally 
affected, although the incidence in the former is higher 
during pregnancy 12.
Although a satisfactory recovery for patients with BP is 
thought to depend on the combined treatment with ster-
oids and anti-viral drugs during the  rst week after on-
set, the role of this therapeutic association has recently 
been rediscussed 13 14. Some Authors are also suggesting 
that about 20-31% of patients with BP not receiving an 
appropriate treatment, run a higher risk of residual facial 
muscle weakness with complications, such as synkinesis 
or hypercontractures that would cause secondary physi-
ological and psychological sequelae 15-17. The most im-
portant prognostic factors for an unsatisfactory prognosis 
are: complete palsy, absence of recovery in the  rst three 
weeks and age over 60 years.
Despite the many studies carried out on the incidence 
and risk factors of BP, studies investigating all the as-
pects of this pathological condition are indeed very few. 
More studies are, instead, essential in order to be able to 
associate diagnosis and treatment with suitable preven-
tion, especially for patients at higher risk of recurrences 
and complications.
The aim of the present study was to estimate the inci-
dence of BP in a large health district of a South-Euro-
pean Capital city, and to study potential risk factors that 
may in uence BP occurrence, applying a case-control 
design.
Methods
The area under study refers to the health district “ASL 
RM/E” of Rome, Italy (Fig. 1). This area has a popula-
tion of about 500,000 inhabitants. Acute health condi-
tions, in this area, are managed by four Emergency De-
partments (ED) belonging to different Hospitals where, 
according to the National Health System, all patients 
are systematically referred by general practitioners. All 
patients admitted to those four EDs, between 1st Janu-
ary 2006 and 31st December 2008, with a diagnosis of 
BP, were included in the study. Diagnosis was always 
made by the Otolaryngologist, as consultant for the ED 
physician. Diagnosis was based on: a negative otoscopic 
examination and lack of other possible coexisting signs/
symptoms, as well as on results of imaging techniques 
(computed tomography [CT], magnetic resonance im-
aging  [MRI])  when  considered  useful.  Audiological 
tests, including stapedial re ex elicitation, were only 
Fig. 1. Rome (Italy) and its Municipals. The four Emergency Departments included in the study belong to the XVIII, XIX and XX Municipals (circled).S. Monini, et al.
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occasionally carried out and were not taken into account 
in this study.
An estimate of the total general population referring to 
each hospital, in that period of time, was carried out, 
obtaining population data from the authorities of each 
municipal area forming the health district. The cumu-
lative  incidence  has  been  calculated  by  dividing  the 
number of BP patients in each ED (numerator) by the 
total general population referring to each ED (denomi-
nator).
All patients included in the estimation of BP incidence 
could potentially constitute the cases of the case-control 
study. However, of the 381 cases detected and used to 
calculate the cumulative incidence of the disease, 177 
(46.5%) were lost to follow-up. The case-control study 
was carried out only on the cohort collected at the ED 
of the Authors’ Hospital, i.e., on 82 patients. For each 
of these four controls were selected as follows: Each 
time a new case was selected, four patients that arrived 
at the outpatient ENT ward, during the same week as the 
case and that met the inclusion criteria outlined below 
have been recruited. Therefore, controls were matched 
for hospital admission, week of disease onset, and cli-
mate conditions. In order to meet the inclusion criteria, 
control patients should have had an ENT-related patho-
logical condition or symptom. All cases and all controls 
underwent a standardized telephone interview (Table I) 
performed by a trained physician, including questions 
concerning:
r EJBHOPTJT
USFBUNFOU
EVSBUJPOPGJMMOFTT
UJNFPGSFDPW-
ery and outcome;
r DPOTUJUVUJPOBMGBDUPST	BHF
TFY
QSFHOBODZ
BOEDPFY-
isting pathological conditions (diabetes, hypertension, 
past herpetic infections).
The resulting dataset was analyzed using multiple condi-
tional logistic regression.
The present study was approved by the Ethics Committee 
of the University Hospital which acted as coordinator. All 
the patients interviewed were correctly informed about 
the aim of the study.
Results
The cumulative incidence of BP for each of the four EDs 
ranged from 48.1 to 57.3 per 100,000 per year. The cumu-
lative incidence for the global area was 53.3 per 100,000 
per year (Table II).
Age was normally distributed (mean value 50.3 years [SD 
19.5]). Males were slightly more affected (53.7%) than 
females and 2.4% of females were pregnant at the time of 
BP onset. BP duration had a log-normal distribution and 
a geometric mean of 45.9 days (SD 142.5; min 1; max 
1.825). The comparison between cases and controls is 
outlined in Table III, while the ENT diseases in the Con-
trol group are listed in Table IV.
After the case-mix adjustment, all risk factors consid-
ered in the case-control study had a similar distribu-
tion both in the case and control groups, except for age 
(Table V); the odds of PB increased on average by 2% 
for each one-year increase in age with a linear trend 
(95% CI 1-3%; p = 0.005). Pregnancy was of borderline 
signi cance. The effect of climate conditions (Fig. 2) 
could not be assessed since the study was matched for 
those variables.
Table I. Questionnaire for the subjects included in the incidence and the 
case/control study.
Incidence Study Group
Did you perform a CT scan?
Did you perform an MRI scan?
Which medical therapy has been prescribed?
Did you perform any physical rehabilitation?
For how long have you suffered from facial palsy (FP)?
Did the FP fully recover?
Did you suffer from any FP sequela?
How many episodes of FP did you have?
Case-Control Study
Did anybody in your family ever suffer from FP?
Do you suffer from diabetes?
Are you affected by hypertension?
Have you ever had measles or Herpes zoster?
Have you ever had Herpes symplex?
Did you have FP during pregnancy?
Did you have FP after anti-ﬂu vaccination?
Table II. Incidence of BP distribution in the four Hospitals belonging to the Health District “ASL RM/E” in Rome, Italy.
Hospital Total number of cases of BP, in 3 years Estimated population at risk Cumulative incidence (per 100,000 per year)
S. Andrea 125 218,357 57.25
S. Filippo 97 180,557 53.72
Gemelli 94 180,557 52.06
S. Carlo 65 135,038 48.13
Total 381 714,509 53.32Epidemiology of Bell’s palsy
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Discussion
This study consisted of two parts: estimate of the cumu-
lative incidence of BP and assessment of some potential 
risk factors for BP onset. There are two main limitations 
potentially affecting the estimation of incidence. On the 
one hand, the diagnosis of BP can be made by different 
medical expertise, in which case, the results cannot be 
generalized. However, in all our cases, the diagnosis was 
made by emergency doctors at the Hospital Emergency 
Department, always supported both by ENT or Neuro-
logical specialists and negative imaging results (MRI, 
CT). Our denominators could also be unreliable. By us-
ing population data, it has been assumed that all BP pa-
tients living in the study areas were admitted to the Hos-
pitals belonging to the same areas, and that no patients 
affected by BP and living in other areas were admitted 
to the hospitals belonging to the study areas. However, 
although the exact incidence of BP is not yet known, 
BP can be considered a rare disease. Therefore, it would 
appear that our denominators may be considered signi -
cant. In fact, if one carries out a sensitivity analysis and 
changes the denominators by a 10% factor, the resulting 
cumulative incidence would change by about 5 points 
only. In this regard, the fact that there is no heterogeneity 
among the four Hospitals, which all show similar inci-
dence rates (Table I), is reassuring.
In contrast to most viral infections, BP can be consid-
ered endemic rather than epidemic in nature. This would 
mainly be related to post-primary infection symbiosis 
between the virus and human host as well as to its self-
inoculated  pathogenesis.  Although  endemic,  BP  has 
been shown to be fairly frequent worldwide, however 
with a different incidence 1. This latter can be in rela-
tion to territorial (demographic, climatic, seasonal and 
probably racial), as well as socio-economic (Health Care 
System, methodology of study) factors. In fact, method-
ology may be considered the weakest point of most of 
Table III. Comparison between cases and controls.
Variable and Category Cases Controls Total
Mean age (SD) 50.3 (19.5) 44.1 (22.6) 45.4 (22.1)
Male sex 44 (53.7%) 168 (51.2%) 212 (51.7%)
Diabetes mellitus 11 (13.4%) 57 (17.4%) 68 (19.6%)
Varicella 67 (81.7%) 273 (83.2%) 340 (82.9%)
Herpes simplex 32 (39.0%) 130 (39.6%) 162 (39.5%)
Herpes zoster 8 (9.8%) 46 (14.0%) 54 (13.2.%)
Hypertension 32 (39.0%) 125 (38.1%) 157 (38.3%)
Pregnancy 2 (2.4%) 2 (0.6%) 4 (1.0%)
Anti-ﬂu vaccination 5 (6.1%) 16 (4.9%) 21 (5.1%)
Total 82 (100%) 328 (100%) 410 (100%)
Table IV. Types of diagnosis in the control group.
Diagnosis in the control group n. (%)
Acute dyspnoea 10 (3.04)
Acute pharyngitis 11 (3.35)
Acute mastoiditis 3 (0.91)
Acute external otitis  48 (14.63)
Acute otitis media 31 (9.45)
Acute scialoadenitis 2 (0.60)
Acute sinusitis 13 (3.96)
Acute tonsillitis 8 (2.43)
Anaphylactic shock 2 (0.60)
Ear perichondritis 3 (0.91)
Earwax plug 12 (3.65)
External auditory canal foreign body 4 (1.21)
External ear pimple 3 (0.91)
Facial trauma 20 (6.09)
Foreign body ingestion 8 (2.43)
GERD 12 (3.65)
Haemophtysis 2 (0.60)
Laterocervical lymphoadenopathy 2 (0.60)
Mononucleosis 2 (0.60)
Nasal foreign body 3 (0.91)
Nasal fractures 27 (8.23)
Nose pimple 2 (0.60)
Nosebleeding 84 (25.60)
Peritonsillar abscess 2 (0.60)
Submandibular lymphadenopathy 1 (0.30)
Sudden deafness 12 (3.65)
Vocal chord oedema 1 (0.30)S. Monini, et al.
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the previous epidemiologic studies. Such studies should, 
in fact, be based on three main principles: correct diag-
nosis, adequate sample number and case-control statisti-
cal analysis.
The  present  study  has  been  following  these  principles 
with a diagnosis achieved, in 50% of the cases, by a multi-
disciplinary approach, and imaging-supported in the oth-
er 50%, as exclusion criterion. Although the sample has 
been limited to 16% of the entire City population, it has 
been shown to be adequate for the analysis of the annual 
incidence since relative values for each Emergency De-
partment overlapped, with 50 cases of BP per year, hence 
slightly higher than the maximum value reported in the 
literature 1.
As in previous investigations 18 19, this study also included 
a case-control statistical analysis, having as its major tar-
get the risk index assessment of the main factors involved 
in BP onset and prognostic recovery between the affected 
and unaffected population. These factors have been se-
lected among those suggested in the literature, i.e., hy-
pertension, diabetes, primary Herpes Simplex infection, 
anti- in uenza vaccination in the three months prior to BP, 
age, pregnancy and climatic factors 18-21.
There is one main limitation potentially affecting the eval-
uation of BP risk factors, in terms of selection bias. In fact, 
46.5% of the cases have not been interviewed. However, 
this was not due to patients’ self-selection but to logistic 
problems and, therefore, losses to follow-up occurred in a 
fairly random fashion.
The fact that elderly people are more likely to be affected 
by BP than young people, with a linear trend, represents 
an interesting  nding. It is tempting to suggest that a more 
thorough investigation focused on the aetiology of this 
disease should take into account also different attitudes or 
metabolic assets linked to aging, which may represent the 
real risk factors for BP.
The present study has revealed a mean age value of BP pa-
tients higher than that reported in the literature, with a lower 
inferior value (8 vs. 15), higher superior value (87 vs. 60), 
minimal percentage in children under 8 years old (2.4%) 
and a high percentage in adults over 60 years (40%). These 
latter data could be in relation to the longer life expectancy 
that during the last 30 years has been recorded in the Coun-
try of reference, contrary to the rest of the world in which 
this trend has been noticed only since 2007, long after the 
major previous epidemiological studies were carried out.
Table V. Multiple conditional logistic regression output, modelling the odds of BP occurrence.
Factor and Category Mutually adjusted OR P Lower 95% CI Upper 95% CI
Male vs. Female 1.37 0.241 0.81 2.32
1 year increase in age 1.02 0.005 1.01 1.03
Diabetes 0.59 0.185 0.27 1.29
Varicella 0.74 0.397 0.37 1.48
Herpes simplex 0.99 0.959 0.58 1.68
Herpes zoster 0.60 0.241 0.26 1.41
Hypertension 0.74 0.295 0.42 1.30
Pregnancy 5.40 0.099 0.73 40.20
Vaccination 1.26 0.711 0.37 4.27
Fig. 2. Monthly distribution of BP in the study group.Epidemiology of Bell’s palsy
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